These PTH–cyclin D1, line PC2 transgenic mice express a transgene containing the human cyclin D1 gene (CCND1) and develop chronic biochemical hyperparathyroidism and enlarged, hypercellular parathyroid glands.
Andrew Arnold, University of Connecticut School of Medicine
Genetic Background | Generation |
---|---|
|
Allele Type |
---|
Transgenic (Inserted expressed sequence) |
These transgenic mice overexpress the human cyclin D1 gene (CCND1) in the parathyroid glands under the direction of the human PTH gene regulatory elements. Founder line PC2 has an estimated 11 copies of the transgene.
The transgene fusion mimics an inversion found in some human parathyroid adenomas.
Higher levels of serum calcium and parathyroid hormone are detectable as early as 6 to 9 months of age in transgenic mice, with the elevated levels becoming significant by 10 months of age. By 5 months of age, transgenic mice exhibit increased parathyroid cell proliferation rates, and by 5-6 months increased parathyroid gland size and hypercellularity is observed, sometimes with features suggestive of adenomas.
Transgenic mice also have decreased bone volume, evidence of increased bone turnover, increased numbers of osteoclasts and bone formation in the calvaria, as well as fewer calcium receptors, which is similar to features observed in human hyperparathyroidism.
Mice that are hemizygous for the transgene are viable and fertile. The Donating Investigator has not attempted to make the strain homozygous; it is not known if homozygotes are viable.
A transgenic construct designed by Dr. Andrew Arnold (University of Connecticut School of Medicine, Farmington, Connecticut) containing a 16kb genomic fragment of the human CCND1 gene (all exons and introns, 1.1kb 5'-flanking region, and 1kb 3'-flanking region) under the control of the human PTH gene promoter (approximately 5 kb of upstream, 5'-regulatory region, and the first 66 bp of untranslated/non-coding exon 1), was injected into the pronuclei of fertilized FVB/N mouse eggs. Founder line PC2, which has an estimated 11 copies of the transgene, was subsequently established. Upon arrival, sperm was cryopreserved. To establish our live colony, an aliquot of frozen sperm was used to fertilize FVB/NJ oocytes (Stock No. 001800).
Expressed Gene | CCND1, cyclin D1, human |
---|---|
Site of Expression | Parathyroid glands |
Allele Name | transgene insertion PC2, Andrew Arnold |
---|---|
Allele Type | Transgenic (Inserted expressed sequence) |
Allele Synonym(s) | PC2; Tg(PTH-CCND1)2Anar |
Gene Symbol and Name | Tg(PTH-CCND1)PC2Anar, transgene insertion PC2, Andrew Arnold |
Gene Synonym(s) | |
Promoter | PTH, parathyroid hormone, human |
Expressed Gene | CCND1, cyclin D1, human |
Site of Expression | Parathyroid glands |
Strain of Origin | FVB/N |
Chromosome | UN |
Molecular Note | 5.2 kb of the upstream regulatory region the human PTH gene was used to drive long range tissue specific expression of the full-length 16 kb human cyclin D1 gene in conjunction with its own promoter elements for basal expression. This fusion mimics an inversion found in some human parathyroid adenomas. Three lines were created (1, 2, and 4 with 3, 11, and 15 copies of the transgene, respectively). Line 2 was selected as the representative line. |
When maintaining a live colony, hemizygous mice may be bred together, to wildtype siblings, or to FVB/NJ inbred mice (Stock No. 001800). The Donating Investigator has not attempted to make the strain homozygous.
When using the PTH–cyclin D1, line PC2 mouse strain in a publication, please cite the originating article(s) and include JAX stock #028218 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Hemizygous or non carrier for Tg(PTH-CCND1)PC2Anar |
Frozen Mouse Embryo | FVB/N-Tg(PTH-CCND1)PC2Anar/J Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | FVB/N-Tg(PTH-CCND1)PC2Anar/J Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | FVB/N-Tg(PTH-CCND1)PC2Anar/J Frozen Embryo | $3373.50 |
Frozen Mouse Embryo | FVB/N-Tg(PTH-CCND1)PC2Anar/J Frozen Embryo | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.